![](https://monteverdelaw.com/wp-content/uploads/case-logo/alexion-pharmaceuticals-inc.jpg)
Alexion Pharmaceuticals, Inc. (ALXN) relating to its proposed acquisition by AstraZeneca, PLC. Under the terms of the agreement, Alexion shareholders will receive 2.1243 shares of AstraZeneca and $60.00 in cash per share.
Alexion Pharmaceuticals, Inc. (ALXN) relating to its proposed acquisition by AstraZeneca, PLC. Under the terms of the agreement, Alexion shareholders will receive 2.1243 shares of AstraZeneca and $60.00 in cash per share.